0000899243-18-023647.txt : 20180831
0000899243-18-023647.hdr.sgml : 20180831
20180831162057
ACCESSION NUMBER: 0000899243-18-023647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180829
FILED AS OF DATE: 20180831
DATE AS OF CHANGE: 20180831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strum Jay
CENTRAL INDEX KEY: 0001706851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 181050365
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-29
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001706851
Strum Jay
C/O G1 THERAPEUTICS, INC.
79 T.W. ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
Chief Scientific Officer
Comomon Stock
2018-08-29
4
S
0
600
58.403
D
57969
D
Comomon Stock
2018-08-29
4
S
0
3500
59.10
D
54469
D
Comomon Stock
2018-08-29
4
S
0
700
60.004
D
53769
D
Comomon Stock
2018-08-29
4
S
0
200
61.00
D
53569
D
Comomon Stock
2018-08-30
4
S
0
500
59.266
D
53069
D
Comomon Stock
2018-08-30
4
S
0
4500
60.054
D
48569
D
The price represents the weighted average price with a low of $57.79 and a high of $58.695. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 through 6.
The price represents the weighted average price with a low of $58.80 and a high of $59.72.
The price represents the weighted average price with a low of $59.88 and a high of $60.14.
The price represents the weighted average price with a low of $60.95 and a high of $61.05.
The price represents the weighted average price with a low of $58.65 and a high of $59.58.
The price represents the weighted average price with a low of $59.68 and a high of $60.33.
/s/ Brian Shea, attorney-in-fact
2018-08-31